Category: St. Jude Medical
Medical device maker St. Jude Medical enrolls the 1st patient in a post-market study of its Enlightn renal denervation system, hoping to expand research to patients with less severe forms of hypertension.
Medtech giant St. Jude Medical (NYSE:STJ) launched a new trial of its Enlightn renal denervation system, hoping to demonstrate the value of the technology in a larger clutch of patients.
St. Jude Medical's profits for the 4th quarter and 2012 top expectations on Wall Street, despite lower sales and earnings numbers.
St. Jude Medical (NYSE:STJ) posted sales and profit declines for the 4th quarter and 2012, but beat analysts' expectations anyway.
A Massachusetts judge stays a handful of patent infringement lawsuit filed by Body Science while the patents are reviewed by regulators.
St. Jude Medical wins European CE Mark approval for its next-generation Amplatzer Amulet left atrial appendage closure device.
European regulators approved St. Jude Medical's (NYSE:STJ) next-generation Amplatzer Amulet heart implant, a device used to close the heart's left atrial appendage in patients at risk of stroke due to non-valvular atrial fibrillation.
St. Jude Medical wins CE Mark approval in the European Union for its ViewFlex Xtra intracardiac echocardiography catheter.
Medical device maker St. Jude Medical (NYSE:STJ) won CE Mark approval in the European Union for its ViewFlex Xtra intracardiac echocardiography catheter for use with the device giant's ViewMate Z ultrasound console.
The upgraded system offers one-handed use, an ergonomic handle and 4-way tip deflection, according to a press release.
Medical device maker launches commercial sales of its OneShot renal denervation system in Europe, Middle East, Africa, Asia and Latin America.
Medical device maker Covidien (NYSE:COV) this week announced commercial launch of its OneShot renal denervation system in markets around the world, bringing the company up to speed with some of its renal denervation rivals.
The FDA grants pre-market approval to St. Jude Medical's Merlin.net, a web-based remote monitoring system for patients with cardiac rhythm management implants.
St. Jude Medical (NYSE:STJ) said the FDA approved the latest version of its Merlin.net remote monitoring system for pacemakers and defibrillators.